BVMF
RADL3
Market cap6.24bUSD
Apr 11, Last price
21.38BRL
1D
3.84%
1Q
1.96%
Jan 2017
-64.43%
IPO
53.04%
Name
Raia Drogasil SA
Chart & Performance
Profile
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 38,864,455 14.40% | 33,973,790 16.88% | 29,067,380 20.48% | |||||||
Cost of revenue | 36,509,411 | 31,959,227 | 27,313,751 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 2,355,044 | 2,014,563 | 1,753,629 | |||||||
NOPBT Margin | 6.06% | 5.93% | 6.03% | |||||||
Operating Taxes | 206,508 | 129,550 | 178,241 | |||||||
Tax Rate | 8.77% | 6.43% | 10.16% | |||||||
NOPAT | 2,148,536 | 1,885,013 | 1,575,388 | |||||||
Net income | 1,197,694 13.53% | 1,054,973 5.91% | 996,112 32.47% | |||||||
Dividends | (465,901) | (324,082) | ||||||||
Dividend yield | 0.93% | 0.83% | ||||||||
Proceeds from repurchase of equity | (73,285) | |||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,585,207 | 1,463,068 | 186,356 | |||||||
Long-term debt | 10,511,293 | 9,541,157 | 8,852,263 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 366,017 | 382,218 | 302,942 | |||||||
Net debt | 11,553,758 | 10,576,951 | 8,600,599 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,912,580 | 1,785,327 | 1,682,255 | |||||||
CAPEX | (1,283,653) | (1,304,581) | (1,188,782) | |||||||
Cash from investing activities | (1,412,911) | (1,307,123) | (1,229,582) | |||||||
Cash from financing activities | (383,989) | (499,424) | (375,250) | |||||||
FCF | 1,209,774 | (103,919) | 447,847 | |||||||
Balance | ||||||||||
Cash | 543,708 | 412,321 | 433,541 | |||||||
Long term investments | (966) | 14,953 | 4,479 | |||||||
Excess cash | ||||||||||
Stockholders' equity | 4,013,427 | 5,961,509 | 5,349,419 | |||||||
Invested Capital | 14,503,427 | 13,173,305 | 11,004,494 | |||||||
ROIC | 15.53% | 15.59% | 15.37% | |||||||
ROCE | 16.24% | 15.29% | 15.94% | |||||||
EV | ||||||||||
Common stock shares outstanding | 1,695,194 | 1,719,821 | ||||||||
Price | 22.00 -25.17% | 29.40 28.89% | 22.81 -6.13% | |||||||
Market cap | 49,838,704 27.05% | 39,229,118 -6.14% | ||||||||
EV | 60,487,955 | 47,891,796 | ||||||||
EBITDA | 3,267,009 | 3,675,909 | 3,269,167 | |||||||
EV/EBITDA | 16.46 | 14.65 | ||||||||
Interest | 812,719 | 737,787 | 292,690 | |||||||
Interest/NOPBT | 34.51% | 36.62% | 16.69% |